Literature DB >> 2753889

Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor.

R S Thies1, A Ullrich, D A McClain.   

Abstract

Recently, we have described a COOH-terminal deletion mutation of the human insulin receptor (HIR delta CT) that exhibits normal insulin-mediated kinase activity and endocytosis, but is inefficient in stimulating glucose transport and glycogen synthase (McClain, D. A., Maegawa, H., Levy, J., Huecksteadt, T., Dull, T. J., Lee, J., Ullrich, A., and Olefsky, J.M. (1988) J. Biol. Chem. 263, 8904-8911; Maegawa, H., McClain, D. A., Freidenberg, G., Olefsky, J. M., Napier, M., Lipari, T., Dull, T. J., Lee, J., and Ullrich, A. (1988) J. Biol. Chem. 263, 8912-8917). In this paper, we report that despite this defect in metabolic signaling, the truncated receptor exhibits augmented mitogenic activity compared to normal receptors. These results were verified in three independently isolated clones of Rat 1 fibroblasts transfected with the HIR delta CT cDNA. The increase in insulin sensitivity of mitogenic stimulation was proportional to the number of HIR delta CT receptors expressed on the cells. By contrast, only the cells with normal receptors and none of the HIR delta CT clones exhibit increased sensitivity for a metabolic action of insulin, the stimulation of glucose uptake. Stimulation of cells by other mitogens and autoradiographic analysis confirm that the enhanced mitogenic effects seen in HIR delta CT cells are attributable only to the presence of the truncated insulin receptors. These receptors mediate the tyrosine phosphorylation of a number of cellular proteins, and the pattern of these phosphorylations differs quantitatively from that seen in cells with normal receptors. We conclude: 1) The COOH terminus plays a role in signaling metabolic actions of insulin, perhaps through its recognition of substrates for the receptor kinase. 2) By contrast, the COOH terminus is an inhibitory regulator of mitogenesis, and removal of the terminal 43 amino acids converts the receptor from a moderately active growth signaler to a very active one. 3) The changes seen in biologic activities of the HIR delta CT receptor are associated with quantitative changes in substrate phosphorylation by the receptor kinase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753889

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency.

Authors:  B F Hansen; G M Danielsen; K Drejer; A R Sørensen; F C Wiberg; H H Klein; A G Lundemose
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

Review 2.  Autophosphorylation: a salient feature of protein kinases.

Authors:  J A Smith; S H Francis; J D Corbin
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

3.  The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts.

Authors:  L Laviola; F Giorgino; J C Chow; J A Baquero; H Hansen; J Ooi; J Zhu; H Riedel; R J Smith
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction.

Authors:  D W Rose; A R Saltiel; M Majumdar; S J Decker; J M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

5.  Changes in insulin-receptor tyrosine, serine and threonine phosphorylation as a result of substitution of tyrosine-1162 with phenylalanine.

Authors:  J M Tavaré; M Dickens
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

6.  Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions.

Authors:  D Liu; C S Zong; L H Wang
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

7.  Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.

Authors:  P A King; E D Horton; M F Hirshman; E S Horton
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  Abnormal regulation of ribosomal protein S6 kinase by insulin in skeletal muscle of insulin-resistant humans.

Authors:  J Sommercorn; R Fields; I Raz; R Maeda
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations.

Authors:  M Dickens; J E Chin; R A Roth; L Ellis; R M Denton; J M Tavaré
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

10.  Activation of glucose transport by a natural mutation in the human insulin receptor.

Authors:  N Longo; S D Langley; L D Griffin; L J Elsas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.